Balance Sheet
Accounts PayablesAccumulated ExpensesCommon EquityConvertible DebtLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsPayablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Medicale (MCLE) Cash & Equivalents (2021 - 2024)

Medicale's Cash & Equivalents history spans 4 years, with the latest figure at $159.0 for Q4 2024.

  • For Q4 2024, Cash & Equivalents changed 0.0% year-over-year to $159.0; the TTM value through Dec 2024 reached $159.0, changed 0.0%, while the annual FY2024 figure was $159.0, 0.0% changed from the prior year.
  • Cash & Equivalents reached $159.0 in Q4 2024 per MCLE's latest filing, roughly flat from $159.0 in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $23900.0 in Q1 2021 to a low of $159.0 in Q4 2022.
  • Average Cash & Equivalents over 4 years is $4878.6, with a median of $159.0 recorded in 2022.
  • Peak YoY movement for Cash & Equivalents: tumbled 98.56% in 2022, then changed 0.0% in 2023.
  • A 4-year view of Cash & Equivalents shows it stood at $3379.0 in 2021, then tumbled by 95.29% to $159.0 in 2022, then changed by 0.0% to $159.0 in 2023, then changed by 0.0% to $159.0 in 2024.
  • Per Business Quant, the three most recent readings for MCLE's Cash & Equivalents are $159.0 (Q4 2024), $159.0 (Q3 2024), and $159.0 (Q2 2024).